Canada markets closed

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.40000.0000 (0.00%)
At close: 03:27PM EST
Full screen
Previous Close0.4000
Open0.4000
Bid0.4000 x 0
Ask0.4050 x 0
Day's Range0.4000 - 0.4000
52 Week Range0.2300 - 0.4700
Volume27,347
Avg. Volume70,109
Market Cap54.62M
Beta (5Y Monthly)0.28
PE Ratio (TTM)13.33
EPS (TTM)0.0300
Earnings DateMay 09, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSept 02, 1999
1y Target Est0.80
  • Simply Wall St.

    Microbix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)

    Microbix Biosystems ( TSE:MBX ) First Quarter 2024 Results Key Financial Results Revenue: CA$8.41m (up 236% from 1Q...

  • GlobeNewswire

    Microbix Reports Record Results for Q1 Fiscal 2024

    Record Revenues of $8.4 million and Record Net Income of $2.5 millionMISSISSAUGA, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2024 ended December 31, 2023 (“Q1”), with record quarterly revenues and a record quarterly profit, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients and devices, and

  • GlobeNewswire

    Microbix Schedules Release of Results for Q1 Fiscal 2024

    Results Release and Webinar Discussion on Morning of February 14, 2024MISSISSAUGA, Ontario, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2024 ended December 31, 2023 prior to the start of trading on February 14, 2024. Furthermore, at 10:00 AM ET on that day, Micro